A recent trial showed that nicotinamide riboside supplementation might reduce airway inflammation in patients with COPD who ...
Explore strategies for controlling COPD and improving health, with a focus on management and lifestyle changes.
We've all felt winded when taking the stairs or dealt with a cough from time to time. But if these issues linger, they could ...
In today’s fast-paced world, respiratory issues have become increasingly common, affecting individuals of all ages. Whether it’s due to environmental pollutants, allergens, or chronic conditions like ...
Emphysema is a chronic lung condition that affects millions of people worldwide and can make everyday activities such as ...
If these trials confirm the findings, benralizumab could become the first new therapy approved for eosinophilic exacerbations ...
Study reveals the Prospector calculator reduces antibiotic prescriptions in COPD exacerbations, improving outcomes and ...
About 10% of Sri Lankans over the age of 40 are affected by Chronic Obstructive Pulmonary Disease (COPD), a condition often linked to smoking, prolonged exposure to air pollution, or untreated asthma, ...
Depemokimab is a follow-up to GSK's Nucala (mepolizumab), a once-monthly IL-5 inhibitor approved for severe asthma, CRSwNP, ...
The smoking rates have dropped among men but are rising in women, increasing the risks of cancer among young female smokers, ...
Erdosteine is a multimechanism, mucolytic agent that decreases the sputum viscoelastic properties and bacterial adhesion to the cell membrane, endowed with bronchial anti-inflammatory activity and ...